Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.30 USD | -0.41% |
|
-2.86% | -5.14% |
Jun. 04 | Exact Sciences Corporation, Q1 2025 Earnings Call, May 01, 2025 | |
Jun. 03 | Exact Sciences Corporation Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 08:40 AM |
Projected Income Statement: Exact Sciences Corporation
Annual
Quarterly
Annual
Quarterly
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 1,491 | 1,767 | 2,084 | 2,500 | 2,759 | 3,094 | 3,489 | 3,917 |
Change | - | 18.49% | 17.95% | 19.93% | 10.37% | 12.14% | 12.77% | 12.26% |
EBITDA 1 | 26.08 | -188.1 | -143.4 | 218.8 | 323.4 | 438.3 | 599.2 | 788.1 |
Change | - | -821.16% | 23.76% | 252.58% | 47.83% | 35.53% | 36.72% | 31.52% |
EBIT 1 | -137.3 | -599.4 | -580 | -259.1 | -146.4 | -96.9 | 49.72 | 184 |
Change | - | -336.63% | 3.23% | 55.34% | 43.49% | 33.81% | 151.31% | 270.1% |
Interest Paid 1 | -95.98 | -18.61 | -19.63 | -19.45 | -27.02 | -36.68 | -35.84 | -31.62 |
Earnings before Tax (EBT) 1 | -857.1 | -842.5 | -632.6 | -201.7 | -1,036 | -123 | 43.5 | 204.1 |
Change | - | 1.7% | 24.92% | 68.11% | -413.6% | 88.13% | 135.37% | 369.29% |
Net income 1 | -848.5 | -595.6 | -623.5 | -204.1 | -1,029 | -123.1 | 46.7 | 205.2 |
Change | - | 29.81% | -4.68% | 67.26% | -403.97% | 88.03% | 137.94% | 339.42% |
Announcement Date | 2/16/21 | 2/22/22 | 2/21/23 | 2/21/24 | 2/19/25 | - | - | - |
1USD in Million
Estimates
Forecast Balance Sheet: Exact Sciences Corporation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | -497 | 1,150 | 1,604 | 1,537 | 1,283 | 1,457 | 1,185 | 786 |
Change | - | 331.39% | 39.48% | -4.18% | -16.53% | 13.56% | -18.67% | -33.67% |
Announcement Date | 2/16/21 | 2/22/22 | 2/21/23 | 2/21/24 | 2/19/25 | - | - | - |
1USD in Million
Estimates
Cash Flow Forecast: Exact Sciences Corporation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
CAPEX 1 | 64.35 | 135.8 | 214.5 | 124.2 | 136 | 138.4 | 160.6 | 165.8 |
Change | - | 110.97% | 57.96% | -42.09% | 9.5% | 1.79% | 16.01% | 3.24% |
Free Cash Flow (FCF) 1 | 72.13 | -238 | -438 | 31.93 | 74.55 | 274.2 | 447.8 | 621.8 |
Change | - | -429.96% | -84.04% | 107.29% | 133.48% | 267.77% | 63.34% | 38.84% |
Announcement Date | 2/16/21 | 2/22/22 | 2/21/23 | 2/21/24 | 2/19/25 | - | - | - |
1USD in Million
Estimates
Forecast Financial Ratios: Exact Sciences Corporation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Profitability | ||||||||
EBITDA Margin (%) | 1.75% | -10.64% | -6.88% | 8.75% | 11.72% | 14.17% | 17.18% | 20.12% |
EBIT Margin (%) | -9.21% | -33.92% | -27.83% | -10.36% | -5.31% | -3.13% | 1.43% | 4.7% |
EBT Margin (%) | -57.47% | -47.68% | -30.35% | -8.07% | -37.56% | -3.98% | 1.25% | 5.21% |
Net margin (%) | -56.9% | -33.71% | -29.91% | -8.17% | -37.29% | -3.98% | 1.34% | 5.24% |
FCF margin (%) | 4.84% | -13.47% | -21.02% | 1.28% | 2.7% | 8.86% | 12.84% | 15.88% |
FCF / Net Income (%) | -8.5% | 39.96% | 70.25% | -15.64% | -7.25% | -222.7% | 958.9% | 302.98% |
Profitability | ||||||||
ROA | -20.13% | -10.26% | -9.16% | -4.42% | -0.68% | 1% | 3% | 5% |
ROE | -33.2% | -21.18% | -18.38% | -9.08% | -1.52% | -2.25% | 4.97% | 9.71% |
Financial Health | ||||||||
Leverage (Debt/EBITDA) | - | -6.11x | -11.19x | 7.02x | 3.97x | 3.32x | 1.98x | 1x |
Debt / Free cash flow | - | -4.83x | -3.66x | 48.13x | 17.21x | 5.31x | 2.65x | 1.26x |
Capital Intensity | ||||||||
CAPEX / Current Assets (%) | 4.31% | 7.68% | 10.29% | 4.97% | 4.93% | 4.47% | 4.6% | 4.23% |
CAPEX / EBITDA (%) | 246.78% | -72.19% | -149.57% | 56.77% | 42.05% | 31.58% | 26.8% | 21.04% |
CAPEX / FCF (%) | 89.22% | -57.04% | -48.96% | 388.96% | 182.42% | 50.49% | 35.86% | 26.66% |
Items per share | ||||||||
Cash flow per share 1 | 0.82 | -0.5967 | -1.268 | 0.8666 | 1.143 | 0.8336 | 1.707 | - |
Change | - | -172.76% | -112.46% | 168.36% | 31.89% | -27.07% | 104.76% | - |
Dividend per Share 1 | - | - | - | - | - | - | - | - |
Change | - | - | - | - | - | - | - | - |
Book Value Per Share 1 | 18.68 | 19.77 | 17.26 | 17.34 | 12.94 | 14.11 | 16.18 | 19.06 |
Change | - | 5.83% | -12.72% | 0.5% | -25.37% | 9.02% | 14.66% | 17.83% |
EPS 1 | -5.61 | -3.48 | -3.54 | -1.13 | -5.59 | -0.5634 | 0.2886 | 1.097 |
Change | - | 37.97% | -1.72% | 68.08% | -394.69% | 89.92% | 151.22% | 280.21% |
Nbr of stocks (in thousands) | 159,030 | 172,319 | 177,684 | 180,850 | 185,076 | 188,638 | 188,638 | 188,638 |
Announcement Date | 2/16/21 | 2/22/22 | 2/21/23 | 2/21/24 | 2/19/25 | - | - | - |
1USD
Estimates
2025 * | 2026 * | |
---|---|---|
P/E ratio | -95x | 185x |
PBR | 3.79x | 3.31x |
EV / Sales | 3.73x | 3.23x |
Yield | - | - |
More valuation ratios
* Estimated data
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Sell
Buy

Mean consensus
BUY
Number of Analysts
26
Last Close Price
53.52USD
Average target price
68.86USD
Spread / Average Target
+28.66%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- EXAS Stock
- Financials Exact Sciences Corporation
Select your edition
All financial news and data tailored to specific country editions